EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States

Lukas Janker, Dina Schuster iD, Patricia Bortel, Gerhard Hagn, Samuel M Meier-Menches, Thomas Mohr, Johanna C Mader, Astrid Slany, Andrea Bileck, Julia Brunmair, Christian Madl, Lukas Unger und 8 weitere

Journal of Crohn's and Colitis · 20.10.2023 · 17 (9) · 1514-1527

DOI: 10.1093/ecco-jcc/jjad052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 24.03.2023. Verfasst von Lukas Janker und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Proteomics, Proteome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ulcerative colitis [UC] is a chronic disease with rising incidence and unclear aetiology. Deep molecular phenotyping by multiomics analyses may provide novel insights into disease processes and characteristic features of remission states.

Methods

UC pathomechanisms were assessed by proteome profiling of human tissue specimens, obtained from five distinct colon locations for each of the 12 patients included in the study. Systemic disease-associated alterations were evaluated thanks to a cross-sectional setting of mass spectrometry-based multiomics analyses comprising proteins, metabolites, and eicosanoids of plasma obtained from UC patients during acute episodes and upon remission, in comparison with healthy controls.

Results

Tissue proteome profiling indicated colitis-associated activation of neutrophils, macrophages, B and T cells, fibroblasts, endothelial cells and platelets, and hypoxic stress, and suggested a general downregulation of mitochondrial proteins accompanying the establishment of apparent wound healing-promoting activities including scar formation. Whereas pro-inflammatory proteins were apparently upregulated by immune cells, the colitis-associated epithelial cells, fibroblasts, endothelial cells, and platelets seemed to predominantly contribute anti-inflammatory and wound healing-promoting proteins. Blood plasma proteomics indicated chronic inflammation and platelet activation, whereas plasma metabolomics identified disease-associated deregulations of gut and gut microbiome-derived metabolites. Upon remission several, but not all, molecular candidate biomarker levels recovered back to normal.

Conclusion

The findings may indicate that microvascular damage and platelet deregulation hardly resolve upon remission, but apparently persist as disease-associated molecular signatures. This study presents local and systemic molecular alterations integrated in a model for UC pathomechanisms, potentially supporting the assessment of disease and remission states in UC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeProteomicsProteomeHumansBiomarkersMaleFemaleAdultMiddle AgedRemission InductionPhenotypeCross-Sectional StudiesColonMetabolomicsCase-Control StudiesMultiomics

Stichwörter der Autor:innen

Multi-omicsblood plasmametabolomicsoxylipinstissue proteomics

Substanzen

BiomarkersProteome

Autor:innen und Institutionen

  • Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Joint Metabolome Facility, University of Vienna, Vienna, Austria.
  • Institute of Pathology and Microbiology, Krankenanstalt Rudolfstiftung, Vienna, Austria.
  • Division of General Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • Core Facility Multimodal Imaging, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Dina Schuster, Dietmar Pils, Christopher Gerner

Förderung

  • University of Vienna

Zitieren

APA

Janker, L., Schuster, D., Bortel, P., Hagn, G., Meier-Menches, S. M., Mohr, T., Mader, J. C., Slany, A., Bileck, A., Brunmair, J., Madl, C., Unger, L., Hennlich, B., Weitmayr, B., Del Favero, G., Pils, D., Pukrop, T., Pfisterer, N., Feichtenschlager, T., & Gerner, C. (2023). Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States. Journal of Crohn's and Colitis, 17(9), 1514-1527. https://doi.org/10.1093/ecco-jcc/jjad052

Vancouver

Janker L, Schuster D, Bortel P, Hagn G, Meier-Menches SM, Mohr T, et al. Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States. Journal of Crohn's and Colitis. 2023;17(9):1514-1527. doi:10.1093/ecco-jcc/jjad052

BibTeX
@article{Janker2023,
  author = {Janker, Lukas and Schuster, Dina and Bortel, Patricia and Hagn, Gerhard and Meier-Menches, Samuel M and Mohr, Thomas and Mader, Johanna C and Slany, Astrid and Bileck, Andrea and Brunmair, Julia and Madl, Christian and Unger, Lukas and Hennlich, Barbara and Weitmayr, Barbara and Del Favero, Giorgia and Pils, Dietmar and Pukrop, Tobias and Pfisterer, Nikolaus and Feichtenschlager, Thomas and Gerner, Christopher},
  title = {Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States},
  journal = {Journal of Crohn's and Colitis},
  year = {2023},
  volume = {17},
  number = {9},
  pages = {1514--1527},
  doi = {10.1093/ecco-jcc/jjad052}
}
Kostenlos starten →